Skip to content

Clinical trials

Phase 1 Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 1 Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20053
20066
20074
20081
20096
20106
20114
20121
20133
20142
20152
20162
20173
20182
20194
20201
20213
20222
20232
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Terminated11
Unknown status3
Recruiting3
Active, not recruiting2
Withdrawn2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Pfizer3
Yale University3
AbbVie2
Biogen2
Eli Lilly and Company2
Massachusetts General Hospital2
Mclean Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder66
Schizophrenia15
Major Depressive Disorder11
Psychotic Disorders9
Depressive Disorder4
Stress Disorders, Post-Traumatic3
Anxiety Disorders2
Depressive Disorder, Treatment-Resistant2
Epilepsy2
Mania2

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.